SCHEMBL8122020

SCHEMBL8122020

O=C(Nc1ccccc1O)c1cccc(Cl)c1Cl

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.67
LMNA P02545 5/20 0.67
GAA P10253 4/20 0.67
TP53 P04637 4/20 0.67
HTT P42858 3/20 0.67
HPGD P15428 3/20 0.60
CYP1A2 P05177 1/20 0.60
CYP2C19 P33261 1/20 0.60
RAB9A P51151 4/20 0.58
ALDH1A1 P00352 4/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
POLB P06746 1/20 0.58
METAP2 P50579 1/20 0.58
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
JAK2 O60674 1/20 0.55
KCNMA1 Q12791 1/20 0.55
RORC P51449 1/20 0.53
MAPK1 P28482 2/20 0.51
HSD17B10 Q99714 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9833874 0.88 CYP1A2 (0.77) NPC1LMNAGAATP53HTT
SCHEMBL9621501 0.87 LMNA (0.67) NPC1LMNAGAATP53HTT
SCHEMBL2701801 0.81 HPGD (0.77) NPC1LMNAGAATP53HTT
SCHEMBL21828985 0.81 PTGES (0.64) NPC1GAATP53HPGDCYP1A2
SCHEMBL845142 0.81 LMNA (1.00) NPC1LMNAGAATP53HTT
SCHEMBL27575357 0.80 MEN1 (0.71) NPC1LMNAGAAHPGDCYP1A2
SCHEMBL5357012 0.80 KCNMA1 (0.68) NPC1LMNAGAATP53HTT
SCHEMBL926677 0.80 NPC1 (0.76) NPC1LMNAGAATP53HTT
SCHEMBL28842312 0.79 LMNA (0.96) NPC1LMNAGAATP53HTT
SCHEMBL28842439 0.79 LMNA (0.96) NPC1LMNAGAATP53HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117030873-A Liquid phase analysis method of related substances of rosapine intermediate 武汉世吉药业有限公司 2023-11-10 CN disclosed
EP-0797577-B1 BICYCLIC NONANE AND DECANE COMPOUNDS HAVING DOPAMINE RECEPTOR AFFINITY ALLELIX BIOPHARMA (CA) 2000-07-26 EP disclosed
US-5703072-A TREATMENT OF SCHIZOPHRENIA AND ANXIETY ALLELIX BIOPHARMACEUTICALS (CA) 1997-12-30 US disclosed
EP-0797577-A1 BICYCLIC NONANE AND DECANE COMPOUNDS HAVING DOPAMINE RECEPTOR AFFINITY Allelix Biopharmaceuticals Inc. (CA) 1997-10-01 EP disclosed
WO-1996018630-A1 BICYCLIC NONANE AND DECANE COMPOUNDS HAVING DOPAMINE RECEPTOR AFFINITY ALLELIX BIOPHARMACEUTICALS INC. (CA) 1996-06-20 WO disclosed